Target Intervention of Proteasome Inhibitor PS-341 on Mesenchymal Stem Cells Derived of Multiple Myeloma

陆化,林如峰,沈文怡,葛峥,刘澎,张建富,吴雨洁,费小明,李建勇

DOI: https://doi.org/10.3969/j.issn.1009-6647.2007.24.002

2007-01-01

Abstract:Objective:To analyse the apoptosis and expressions of cytokines IL-6、IL-1β and SCF of mesenchymal stem cells(MSCs),which was derived from Multiple Myeloma(MM) treated with proteasome inhibitor PS-341.Methods:MSCs were incubated in the culture of RPMI1640 with 10% fetal bovine serum(FBS) and were determined by flow cytometric(FCM),then MSCs were exposed to 0 nmol/L,50 nmol/L,100 nmol/L,150 nmol/L,200 nmol/L PS-341 for 4 hours,then cells apoptosis were analyzed by inverted light microscopy and fluorescence microscope with annexin V-FITC/PI dual staining,and reverse transcription polymerse chain reaction(RT-PCR) was performed to detect the expressions of IL-6、IL-1β and SCF.Results:PS-341 induced MSCs apoptosis in a dose-dependent manner.After PS-341 treated expressions of IL-6、IL-1β、SCF of MSCs were decreased(P<0.05),There were no statistics differences of IL-6 and SCF expression between refractory/relapsed group and complete remission(CR)group and PS-341 downregulated the expressions of IL-6 and SCF of MSCs in a dose-dependent manner;IL-1β was significantly inhibited in CR group compared with that in refractory/relapsed group;there were no significant relationship between the expressions of IL-6 and SCF and the expression of IL-1β.Conclusions:Proteasome inhibitor PS-341 can induce MSCs apoptosis and inhibited the expressions of IL-6、IL-1β and SCF,which might be one of mechanisms and targets for MM treatment.